Patrick J. Leavey

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group

P. Leavey, N. Tarbell, M. Gebhardt, 2008, Pediatric blood & cancer.

Phase I study of oral cyclophosphamide and oral topotecan for children with recurrent or refractory solid tumors

P. Leavey, N. Winick, G. Tomlinson, 2004, Pediatric blood & cancer.

Lack of Prognostic Significance of Intratumoral Angiogenesis in Nonmetastatic Osteosarcoma

P. Leavey, J. Reisch, C. Timmons, 2001, Journal of pediatric hematology/oncology.